Mažoji bendrija Hormonų akademija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 213,256 |
| - |
| 57,876 |
| 54,969 |
| - |
| 34.10 |
| 25.78 |
| 54,969 |
| 5,576 |
| 30 |
| 60,515 |
| 0.26 |
| 0.10 |
| - |
| - |
| 30.70 |
| 65,468 |
| 2024 |
|---|
| 100 |
| - |
| -786 |
| -786 |
| - |
| 100.00 |
| -786.00 |
| 54,183 |
| 0 |
| 30 |
| 54,153 |
| 541.53 |
| 0.00 |
| - |
| - |
| -786.00 |
| -786 |
| 2025 |
|---|
| 119,117 |
| - |
| 150 |
| 141 |
| - |
| 100.00 |
| 0.12 |
| 54,333 |
| 34,617 |
| 30 |
| 88,920 |
| 0.46 |
| 0.64 |
| - |
| - |
| 0.13 |
| 150 |
| 2025 |
|---|
| 119,117 |
| - |
| 150 |
| 141 |
| - |
| 100.00 |
| 0.12 |
| 54,333 |
| 34,617 |
| 30 |
| 88,920 |
| 0.46 |
| 0.64 |
| - |
| - |
| 0.13 |
| 150 |
Turnover (€)
2025
Turnover (€)
119,117 €119,017 % *
Sales per employee (€)
-Profit before tax (€)
150 €119 % *
Net Profit (€)
141 €118 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
0.12 %100.02 % *
Equity (€)
54,333 €0 % *
Amounts Payable And Liabilities (€)
34,617 €- *
Non-current Assets (€)
30 €0 % *
CurrentAssets (€)
88,920 €64 % *
Working capital requirement
0.46 -99.92 % *
Debt-to-equity ratio
0.64 - *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
0.13 %100.02 % *
EBIT (€)
150 €119 % *
